sinc
late
two
genet
antigen
distinct
lineag
influenza
b
viru
name
bvictoria
byamagata
cocircul
studi
onestep
realtim
revers
transcriptionpcr
rrtpcr
assay
develop
differenti
bvictoria
byamagata
lineag
assay
evalu
use
vitro
transcrib
control
rna
isol
virus
respiratori
pathogen
virus
shown
high
sensit
good
linear
r
high
specif
use
develop
rrtpcr
assay
clinic
specimen
collect
test
result
identif
clinic
specimen
posit
influenza
b
viru
sampl
identifi
posit
bvictoria
byamagata
lineag
respect
wherea
sampl
neg
influenza
b
viru
rrtpcr
assay
also
examin
use
clinic
isol
influenza
b
virusposit
specimen
reveal
discrep
result
rrtpcr
assay
hemagglutin
inhibit
hi
test
except
one
clinic
isol
differ
antigen
could
discrimin
hi
test
present
result
suggest
highli
sensit
specif
assay
use
diagnos
influenza
virus
also
surveil
influenza
b
c
virus
member
orthomyxovirida
famili
rna
virus
circul
human
caus
respiratori
ill
everi
year
wright
et
al
influenza
virus
compris
number
subtyp
wherea
influenza
b
c
virus
divid
subtyp
wright
et
al
sinc
late
two
genet
antigen
distinct
lineag
influenza
b
viru
name
bvictoria
lineag
byamagata
lineag
cocircul
kanega
et
al
rota
et
al
japan
major
circul
influenza
b
virus
influenza
season
bvictoria
lineag
season
lineag
cocircul
bvictoria
lineag
domin
season
wherea
byamagata
lineag
domin
season
http
wwwwhointinfluenzagisr
laboratoryfluneten
trival
vaccin
current
licens
use
japan
includ
one
lineag
influenza
b
viru
therefor
import
conduct
surveil
know
lineag
predomin
one
time
select
candid
viru
gener
vaccin
convent
two
lineag
influenza
b
viru
differenti
antigen
hemagglutin
inhibit
hi
test
immun
sera
rais
lineag
hi
test
convent
method
defin
type
subtyp
lineag
clinic
isol
howev
timeconsum
complic
process
includ
isol
virus
clinic
specimen
prepar
immun
sera
recent
pcrbase
assay
rapid
diagnosi
influenza
virus
becom
gold
standard
mani
realtim
rtpcr
rrtpcr
assay
report
wang
taubenberg
compar
hi
test
rrtpcr
assay
advantag
abl
perform
rapidli
sensit
specif
use
purifi
rna
clinic
specimen
without
requir
viral
isol
step
japan
sever
rrtpcr
assay
type
influenza
b
virus
subtyp
influenza
virus
develop
use
minor
groov
binder
mgb
probe
assay
scheme
establish
share
prefectur
municip
public
health
http
elsevi
bv
right
reserv
institut
diagnosi
surveil
influenza
virus
nakauchi
et
al
howev
rrtpcr
assay
univers
detect
influenza
b
virus
whose
target
region
nonstructur
protein
ns
gene
bn
rrtpcr
sequenc
primer
probe
list
tabl
abl
discrimin
bvictoria
byamagata
lineag
rrtpcr
assay
discrimin
bvictoria
byamagata
lineag
first
report
bier
et
al
howev
sequenc
forward
primer
two
probe
use
studi
bier
et
al
low
homolog
recent
influenza
b
virus
circul
japan
anoth
rrtpcr
assay
discrimin
two
lineag
report
zhang
et
al
howev
method
use
mgb
probe
result
differ
condit
assay
compar
assay
use
japan
monitor
rapidli
simpli
circul
situat
two
lineag
influenza
b
viru
complement
hi
test
rrtpcr
assay
discrimin
bvictoria
byamagata
lineag
bvic
rrtpcr
byam
rrtpcr
respect
develop
use
mgb
probe
studi
highli
sensit
specif
rrtpcr
assay
detect
discrimin
two
lineag
influenza
b
viru
use
diagnosi
surveil
influenza
b
virus
nucleotid
sequenc
hemagglutinin
ha
gene
influenza
b
virus
post
past
year
global
initi
share
avian
influenza
data
gisaid
databas
align
use
clustalw
softwar
larkin
et
al
basi
sequenc
ha
gene
probe
design
discrimin
bvictoria
byamagata
lineag
nucleotid
nt
nt
probe
sequenc
differ
lineag
sequenc
posit
primer
probe
list
tabl
influenza
virus
includ
studi
isol
use
madindarbi
canin
kidney
mdck
cell
follow
viral
respiratori
pathogen
clinic
isol
use
valid
specif
assay
respiratori
syncyti
virus
b
human
parainfluenza
viru
type
human
rhinoviru
type
b
human
metapneumoviru
type
human
coronavirus
human
bocaviru
human
enteroviru
human
adenovirus
construct
rnaposit
control
bn
bvic
byam
rrtpcr
assay
target
gene
segment
describ
tabl
amplifi
rtpcr
result
pcr
product
contain
promot
transcrib
vitro
procedur
describ
detail
primer
zou
use
rt
use
superscript
iii
revers
transcriptas
kit
thermo
fisher
scientif
waltham
accord
manufactur
instruct
ns
gene
segment
amplifi
use
follow
primer
pair
typebnsf
typebnsr
ha
gene
segment
bbrisban
templat
rna
assay
ns
gene
segment
ha
gene
segment
b
c
bvictoria
lineag
byamagata
lineag
virus
amplifi
use
follow
primer
pair
flub
vic
haf
flub
har
flub
yam
haf
flub
har
respect
pcr
perform
use
phusion
highfidel
dna
polymeras
thermo
fisher
scientif
pcr
product
gel
purifi
use
qiaquick
gel
extract
kit
qiagen
hilden
germani
transcrib
use
ribomax
tm
express
larg
scale
rna
product
system
promega
madison
wi
accord
manufactur
instruct
turbo
dnase
thermo
fisher
scientif
digest
remov
residu
rtpcr
product
transcrib
rna
purifi
twice
use
trizol
reagent
thermo
fisher
scientif
dntp
ntp
remov
use
microspin
column
ge
healthcar
piscataway
nj
accord
manufactur
instruct
purifi
transcrib
rna
quantifi
spectrophotometr
analysi
integr
assess
bioanalyz
agil
technolog
santa
clara
ca
total
rna
prepar
describ
section
confirm
lineag
clinic
isol
region
ha
gene
sequenc
amplifi
region
use
extract
rna
rt
pcr
carri
describ
section
pair
primer
list
tabl
pcr
pcr
product
purifi
sequenc
use
primer
list
tabl
total
rna
prepar
describ
section
nasal
andor
pharyng
swab
collect
patient
influenzalik
ill
suspend
utm
c
kit
copan
brescia
itali
obtain
showa
gener
hospit
japan
specimen
collect
studi
protocol
approv
ethic
committe
niid
studi
perform
complianc
declar
helsinki
inform
consent
obtain
patient
supernat
cultur
mdck
cell
centrifug
g
min
viral
rna
prepar
l
supernat
use
qiaamp
viral
rna
kit
qiagen
accord
manufactur
instruct
slight
modif
viral
rna
elut
l
ave
buffer
qiagen
total
rna
prepar
clinic
specimen
use
qiaamp
viral
rna
kit
qiagen
use
l
clinic
specimen
magmax
tm
viral
isol
kit
thermo
fisher
scientif
use
l
clinic
specimen
kingfish
flex
thermo
fisher
scientif
accord
manufactur
instruct
total
rna
clinic
specimen
elut
l
ave
buffer
qiagen
wherea
total
rna
clinic
specimen
elut
l
elut
buffer
thermo
fisher
scientif
reaction
perform
use
quantitect
probe
rtpcr
kit
qiagen
accord
manufactur
instruct
briefli
l
assay
contain
l
quantitect
probe
pcr
master
mix
l
quantitect
rt
mix
l
rnase
inhibitor
thermo
fisher
scientif
l
forward
primer
l
revers
primer
l
probe
l
distil
water
l
rna
templat
cycl
perform
follow
min
c
activ
rt
follow
initi
denatur
step
min
c
cycl
amplif
denatur
c
anneal
well
extens
c
use
lightcycl
roch
molecular
biochem
basel
switzerland
fluoresc
signal
collect
anneal
extens
step
amplif
data
analyz
use
light
cycler
softwar
accord
manufactur
instruct
rrtpcr
assay
type
influenza
b
virus
subtyp
nakauchi
et
al
also
perform
diagnosi
clinic
specimen
onestep
duplex
rrtpcr
assay
reaction
perform
use
quantitect
viru
rox
vial
kit
qiagen
accord
manufactur
instruct
describ
previous
nakauchi
et
al
test
clinic
isol
use
cultur
medium
l
assay
contain
l
quantitect
viru
nr
master
mix
l
quantitect
viru
rt
mix
l
two
forward
primer
l
two
revers
primer
l
two
probe
l
distil
water
l
cultur
medium
test
clinic
specimen
use
extract
rna
l
rna
templat
use
cycl
perform
follow
min
c
activ
rt
follow
initi
denatur
step
min
c
cycl
amplif
denatur
c
anneal
well
extens
c
use
lightcycl
roch
molecular
biochem
fluoresc
signal
collect
anneal
extens
step
amplif
endpoint
data
analyz
use
light
cycler
softwar
accord
manufactur
instruct
ferret
antisera
rais
mdckgrown
bvictoria
lineag
byamagata
lineag
virus
treat
rdeii
denka
seiken
co
tokyo
japan
remov
nonspecif
inhibitor
dilut
treat
sera
prepar
phosphatebuff
salin
twofold
serial
dilut
sera
mix
ha
unit
antigen
viru
per
well
preincub
min
plate
room
temperatur
turkey
red
blood
cell
ad
plate
incub
min
room
temperatur
hi
titer
sera
determin
highest
dilut
display
hemagglutin
activ
http
appswhointiri
specif
bn
rrtpcr
assay
detect
lineag
influenza
b
viru
bvic
byam
rrtpcr
assay
discrimin
two
lineag
influenza
b
viru
evalu
use
bvictoria
byamagata
influenza
virus
viral
respiratori
pathogen
bn
rrtpcr
assay
react
specif
lineag
influenza
b
viru
data
shown
bvic
rrtpcr
assay
react
specif
bvictoria
byamagata
wherea
byam
rrtpcr
assay
react
specif
byamagata
bvictoria
data
shown
three
assay
show
crossreact
influenza
virus
viral
respiratori
pathogen
data
shown
detect
limit
assay
determin
perform
serial
dilut
vitro
transcrib
control
viral
rna
replic
assay
detect
limit
bn
bvic
byam
rrtpcr
assay
determin
copiesreact
respect
calcul
probit
analysi
use
result
shown
tabl
standard
curv
assay
also
gener
fig
standard
curv
show
linear
relationship
log
viral
titer
cross
point
cp
valu
assay
fig
correl
coeffici
standard
curv
assay
indic
precis
loglinear
relationship
viral
titer
cp
valu
fig
clinic
specimen
nasal
andor
pharyng
swab
patient
influenzalik
ill
n
obtain
bn
rrtpcr
assay
perform
sampl
result
sampl
identifi
posit
influenza
b
viru
twenti
bnsposit
sampl
test
use
bvic
byam
rrtpcr
assay
reveal
sampl
identifi
posit
bvictoria
byamagata
lineag
respect
clinic
isol
influenza
b
virusposit
clinic
specimen
list
tabl
test
use
bn
bvic
byam
rrtpcr
assay
also
convent
perform
hi
test
shown
tabl
facilit
assay
discrimin
two
lineag
primer
probe
bvic
byam
rrtpcr
assay
mix
duplex
rrtpcr
assay
construct
duplex
rrtpcr
assay
probe
bvictoria
label
fam
probe
byamagata
label
vic
list
tabl
use
clinic
specimen
clinic
isol
identifi
posit
influenza
b
viru
duplex
rrtpcr
assay
evalu
clinic
isol
assay
perform
use
cultur
supernat
infect
mdck
cell
directli
without
rna
purif
templat
assay
screen
larg
number
clinic
isol
clinic
specimen
purifi
rna
use
assay
shown
fig
clinic
specimen
determin
bvictoria
byamagata
respect
similarli
clinic
isol
determin
bvictoria
byamagata
respect
fig
bn
rrtpcr
assay
use
detect
influenza
b
virus
bvic
byam
rrtpcr
assay
use
discrimin
two
lineag
influenza
b
viru
shown
good
linear
r
high
sensit
tabl
fig
crossreact
nonspecif
reaction
observ
assay
perform
use
isol
virus
clinic
specimen
data
shown
assay
perform
use
clinic
specimen
sampl
identifi
posit
influenza
b
viru
sampl
neg
bn
rrtpcr
assay
bnsneg
sampl
sampl
identifi
posit
perform
previous
develop
type
rrtpcr
assay
nakauchi
et
al
influenza
b
virus
detect
remain
sampl
bnsposit
clinic
sampl
discrimin
either
bvictoria
byamagata
bvic
byam
rrtpcr
assay
respect
result
suggest
three
rrtpcr
assay
highli
sensit
specif
target
gene
thu
great
use
detect
discrimin
two
lineag
influenza
b
viru
underlin
text
indic
homolog
titer
antisera
b
indic
posit
neg
rrtpcr
assay
result
hi
test
bvic
byam
rrtpcr
assay
compar
use
clinic
isol
tabl
report
antigen
site
analyz
escap
mutant
monoclon
antibodi
tung
et
al
thr
ile
mutat
posit
also
known
affect
antigen
unpublish
data
influenza
surveil
group
japan
consid
data
antigen
differ
thu
hi
test
could
identifi
bvictoria
hi
test
perform
convent
determin
type
subtyp
lineag
influenza
virus
detect
antigen
differ
refer
test
virus
hi
test
use
method
monitor
antigen
circul
influenza
virus
human
select
viru
vaccin
product
howev
hi
test
abl
detect
influenza
virus
test
viru
antigen
differ
refer
viru
combin
bn
bvic
byam
rrtpcr
assay
develop
studi
abl
detect
discrimin
lineag
influenza
b
viru
includ
viru
undetect
hi
test
high
sensit
specif
tabl
howev
rrtpcr
assay
use
compar
antigen
differ
therefor
import
use
rrtpcr
assay
cooper
hi
test
conduct
surveil
influenza
b
virus
facilit
assay
scheme
bvic
byam
rrtpcr
assay
duplex
rrtpcr
assay
discrimin
two
lineag
influenza
b
viru
also
construct
discrep
found
result
duplex
rrtpcr
assay
bvic
byam
rrtpcr
assay
clinic
specimen
clinic
isol
tabl
fig
noteworthi
duplex
assay
could
perform
use
clinic
isol
without
rna
purif
step
sinc
suffici
amount
viral
rna
may
releas
virion
rt
condit
c
min
consid
handl
larg
number
clinic
isol
assay
perform
rapidli
simpli
lower
risk
crosscontamin
rna
purif
step
unnecessari
conclus
highli
sensit
specif
bn
bvic
byam
rrtpcr
assay
develop
studi
use
laboratori
diagnost
test
also
speed
surveil
discrimin
lineag
influenza
b
virus
clinic
specimen
consid
trival
vaccin
current
licens
use
japan
includ
one
lineag
influenza
b
viru
assay
also
power
tool
rapid
recognit
predomin
lineag
influenza
b
viru
one
time
help
decid
candid
viru
includ
vaccin
